305 related articles for article (PubMed ID: 6761899)
1. Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
Sakai T; Ohneda A; Nihei J; Kobayashi T
Tohoku J Exp Med; 1982 Dec; 138(4):427-40. PubMed ID: 6761899
[TBL] [Abstract][Full Text] [Related]
2. [Pancreatic polypeptide response to oral glucose load in patients with liver cirrhosis--interrelationship between PP and other pancreatic endocrine hormones].
Kawakami K
Nihon Naibunpi Gakkai Zasshi; 1988 Mar; 64(3):155-70. PubMed ID: 3294051
[TBL] [Abstract][Full Text] [Related]
3. Human plasma C-peptide immunoreactivity: its correlation with immunoreactive insulin in diabetes, and chronic liver and renal diseases.
Kajinuma H; Kanazawa Y; Sando H; Hayashi M; Kawazu S; Kosaka K
Endocrinol Jpn; 1979 Feb; 26(1):65-73. PubMed ID: 436802
[TBL] [Abstract][Full Text] [Related]
4. Plasma insulin response to various secretagogues in insulinoma.
Ohneda A; Kobayashi T; Nihei J
Tohoku J Exp Med; 1982 Apr; 136(4):447-57. PubMed ID: 6285549
[TBL] [Abstract][Full Text] [Related]
5. Study of A- and B-cell function in beta-thalassemia major.
Maioli M; Pacifico A; Frulio T; Longinotti M
Acta Diabetol Lat; 1983; 20(2):143-52. PubMed ID: 6349202
[TBL] [Abstract][Full Text] [Related]
6. [Insulin secretion in alcoholic hepatopathy: analysis by measurement of C-peptide (author's transl)].
Schlienger JL; Blickle F; Demangeat C; Hasselmann M; Imler M
Nouv Presse Med; 1978 Dec; 7(44):4011-5. PubMed ID: 733568
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of insulin, C-peptide and glucagon in liver cirrhosis.
Gragnoli G; Signorini AM; Tanganelli I
J Endocrinol Invest; 1981; 4(1):1-5. PubMed ID: 7016966
[TBL] [Abstract][Full Text] [Related]
8. Plasma insulin, C-peptide, and blood glucose in portal, hepatic and peripheral veins in liver cirrhosis. Effect of intravenous tolbutamide.
Pelkonen R; Kallio H; Suoranta H; Karonen SL
Acta Endocrinol (Copenh); 1981 Aug; 97(4):496-502. PubMed ID: 7023164
[TBL] [Abstract][Full Text] [Related]
9. [Behavior of plasma insulin, C-peptide and glucagon in normal subjects and in patients with liver cirrhosis].
Gragnoli G; Tanganelli I; Signorini AM
Boll Soc Ital Biol Sper; 1980 Jan; 56(1):69-75. PubMed ID: 7002168
[TBL] [Abstract][Full Text] [Related]
10. Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients.
Kruszynska YT; Goulas S; Wollen N; McIntyre N
J Hepatol; 1998 Feb; 28(2):280-91. PubMed ID: 9514541
[TBL] [Abstract][Full Text] [Related]
11. Serum free C-peptide response to oral glucose loading as a parameter for the monitoring of pancreatic B-cell function in diabetic patients.
Hsieh SD; Kanazawa Y; Akanuma Y
Diabetes Res Clin Pract; 1985 Aug; 1(2):109-14. PubMed ID: 3915258
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-induced insulin secretion in normal diabetic subjects.
Ohneda A; Matsuda K; Chiba M; Iimura Y; Yamagata S
Tohoku J Exp Med; 1975 Jun; 116(2):103-10. PubMed ID: 1154379
[TBL] [Abstract][Full Text] [Related]
13. Disappearance rate of endogenous human C-peptide from blood.
Kuzuya T; Matsuda A
Diabetologia; 1976 Oct; 12(5):519-21. PubMed ID: 976639
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic beta-cell function in cirrhotic patients with and without overt diabetes. C-peptide response to glucagon and to meal.
Marchesini G; Melli A; Checchia GA; Mattioli L; Capelli M; Cassarani S; Zoli M; Pisi E
Metabolism; 1985 Aug; 34(8):695-701. PubMed ID: 3894876
[TBL] [Abstract][Full Text] [Related]
15. Responses of plasma cyclic AMP, serum immunoreactive insulin, C-peptide immunoreactivity and blood sugar levels to glucagon in patients with liver diseases.
Shimamura J; Taketa K; Ide T; Nakata K; Nagashima H
Acta Med Okayama; 1985 Oct; 39(5):385-96. PubMed ID: 3000142
[TBL] [Abstract][Full Text] [Related]
16. Degradation and secretion of insulin in hepatic cirrhosis.
Iwasaki Y; Ohkubo A; Kajinuma H; Akanuma Y; Kosaka K
J Clin Endocrinol Metab; 1978 Oct; 47(4):774-9. PubMed ID: 400732
[TBL] [Abstract][Full Text] [Related]
17. Immunoreactive dog C-peptide level in the pancreatic vein.
Kawanishi K; Nishina Y; Ishida T; Machida S; Yamamoto S; Ofuji T; Sakura N; Yanaihara N
Horm Metab Res; 1980 Dec; 12(12):660-4. PubMed ID: 6162771
[TBL] [Abstract][Full Text] [Related]
18. Insulin and C-peptide in ascitic fluid and plasma and their relative responses to glucagon in patients with cirrhosis.
Akgün S; Samanta A; Ertel NH
J Endocrinol Invest; 1988 Dec; 11(11):789-93. PubMed ID: 3066813
[TBL] [Abstract][Full Text] [Related]
19. Carbohydrate metabolism and pancreatic islet-cell function in thalassemia major.
Costin G; Kogut MD; Hyman C; Ortega JA
Diabetes; 1977 Mar; 26(3):230-40. PubMed ID: 320076
[TBL] [Abstract][Full Text] [Related]
20. Insulin response to glucagon with or without tolbutamide in normal and diabetic subjects.
Chiba M; Ohneda A; Sakai T; Goto Y
Tohoku J Exp Med; 1982 Feb; 136(2):169-75. PubMed ID: 7041329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
